ISPOR - Trend of Cost of Newer Glucose-Lowering Agents in Patients with Type 2 Diabetes Mellitus- Evidence From a Medical System in Taiwan

Full Text

Trend of Cost of Newer Glucose-Lowering Agents in Patients with Type 2 Diabetes Mellitus- Evidence From a Medical System in Taiwan

Abstract

Authors

S Wu K Chang Y Chan

Back to Volume 21, Supplemental S2

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now